Pegasys Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
Condition:   Chronic Hepatitis Interventions:   Drug: Group A, TDF;   Drug: Group B:TDF then TDF and Peginterferon alfa-2a;   Drug: Group C:TDF and Peginterferon alfa-2a then TDF Sponsor:   Ruijin Hospital Active, not recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2016 Category: Research Source Type: clinical trials